EA

Eagle Veterinary Technology Co.,Ltd

Manufactures vet pharma for livestock/aquaculture & distributes premium pet food.

044960 | KO

Overview

Corporate Details

ISIN(s):
KR7044960003
LEI:
Country:
South Korea
Address:
충청남도 예산군 신암면 추사로 235-34, 예산군
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1970, Eagle Veterinary Technology Co., Ltd. is a specialized company in animal health, manufacturing and distributing veterinary pharmaceuticals and premium pet food. Its pharmaceutical division serves the livestock (cattle, swine, poultry) and aquaculture industries, offering a range of products including antibiotics, anthelmintics, and innovative bio-feeds developed through partnerships with global firms. The companion animal division, Haruwell, focuses on the premium market by distributing international brands like Now Fresh, Go! Solutions, and CARU, while also developing its own functional product lines such as the 'Probiomil' probiotic feed and 'SUMMIT' tailored nutrition diets. The company is committed to research and development to improve animal well-being and actively engages with its markets through industry seminars, consumer expos, and corporate social responsibility initiatives.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.0 MB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.0 MB
2025-03-19 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 20.9 KB
2025-03-11 00:00
Audit Report / Information
감사보고서제출
Korean 17.7 KB
2025-03-11 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 652.9 KB
2025-02-21 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 178.9 KB
2025-02-11 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 9.0 KB
2025-02-04 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 8.7 KB
2024-11-14 00:00
Quarterly Report
분기보고서 (2024.09)
Korean 870.7 KB
2024-08-14 00:00
Interim Report
반기보고서 (2024.06)
Korean 864.9 KB
2024-05-16 00:00
Quarterly Report
분기보고서 (2024.03)
Korean 873.5 KB
2024-03-29 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 23.0 KB
2024-03-21 00:00
Audit Report / Information
사업보고서 (2023.12)
Korean 548.1 KB
2024-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 17.7 KB
2024-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 166.2 KB

Automate Your Workflow. Get a real-time feed of all Eagle Veterinary Technology Co.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Eagle Veterinary Technology Co.,Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Eagle Veterinary Technology Co.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

NEOGENOMICS INC Logo
Provides precision oncology testing for cancer diagnostics, therapy guidance, and research.
United States of America
NEO
NeoImmuneTech, Inc. Logo
Develops NT-I7, a T cell-amplifying immunotherapy for cancer and infectious diseases.
United States of America
950220
NEONC TECHNOLOGIES HOLDINGS, INC. Logo
Developing intranasal drug delivery to treat brain cancer & CNS diseases by crossing the BBB.
United States of America
NTHI
Neumora Therapeutics, Inc. Logo
Developing data-driven precision medicines for neuropsychiatric and neurodegenerative disorders.
United States of America
NMRA
Neuphoria Therapeutics Inc. Logo
Develops novel ion channel modulators for treating neuropsychiatric disorders like anxiety & PTSD.
United States of America
NEUP
NEUROCRINE BIOSCIENCES INC Logo
Develops therapies for neurological, neuroendocrine, and neuropsychiatric disorders.
United States of America
NBIX
Neurogene Inc. Logo
Developing genetic medicines using gene therapy for rare and devastating neurological diseases.
United States of America
NGNE
NeuroSense Therapeutics Ltd. Logo
Developing combination therapies for neurodegenerative diseases, with a focus on ALS.
United States of America
NRSN
NewAmsterdam Pharma Co N.V. Logo
Developing oral LDL-lowering therapies for high-risk cardiovascular disease patients.
United States of America
NAMS
Newbury Pharmaceuticals AB Logo
Develops specialty prescription drugs for Scandinavia in oncology, rare diseases & neurology.
Sweden
NEWBRY

Talk to a Data Expert

Have a question? We'll get back to you promptly.